Please note: AABB reserves the right to make updates to this program.
Thursday, November 16, 2017
2:00 – 3:30 PM (ET) 7:00 – 8:30 PM (GMT)
Master Program Number: 17EL-172 (see program format numbers below under Registration)
Educational Track: Quality Education
Topic: Cellular Therapies
Intended Audience: Laboratory Staff, Managers/Supervisors, Medical Directors
Teaching Level: Advanced
Director/Moderator: Nicholas Greco, PhD, Executive Director, Tissue Bank Director, Clinical Assistant Professor, Upstate Medical University, Upstate Cord Blood Bank, Syracuse, NY
Speakers: Diane Kadidlo, Facility Director, Molecular and Cellular Therapeutics (U of M), Technical Supervisor (UMMC), University of Minnesota, UMMC Cell Therapy Laboratory, St. Paul, MN; Petra Craven, PhD, Laboratory Director, Texas Stem Cell, Houston, Texas; Nicholas Greco, PhD, Executive Director, Tissue Bank Director, Clinical Assistant Professor, Upstate Medical University, Upstate Cord Blood Bank, Syracuse, NY
After participating in this educational activity, participants should be able to:
- Identify sources of contaminants in a manufacturing process.
- List the elements of effective strategies to address surveillance.
- Describe how to effectively create and implement a comprehensively designed program to mitigate risks in a cellular manufacturing facility.
This program will demonstrate administrative and engineering practices and policies required to ensure a safely sourced and a sterilely manufactured cellular product (cord blood) produced under aseptic processing conditions with optimum patient safety. This program’s objectives with be accomplished by discussion with these practices.
| || ||
|Single Viewer: Live||
|Single Viewer: On-Demand||
|Group Viewing: Live||
|Group Viewing: On-Demand||
|Group Viewing: Live & On-Demand||